Literature DB >> 6363113

Partial purification and characterization of a colony-stimulating factor secreted by a T lymphocyte clone.

M B Prystowsky, J M Ely, M F Naujokas, E Goldwasser, F W Fitch.   

Abstract

The mouse T lymphocyte clone L2 secretes a minimum of 10 lymphokine activities affecting at least 5 different target cells. Large amounts of colony-stimulating factor (CSF) (8.6 X 10(6) U/ml) can be obtained by stimulating L2 cells with concanavalin A. The major CSF activity secreted by L2 cells has been enriched to a specific activity of approximately 2-4 X 10(8) colonies/mg of protein using hydrophobic-interaction, gel-permeation, ion-exchange, and lectin-affinity chromatography. This preparation of CSF contains no detectable interleukin 2, interleukin 3, or interferon. The major L2-cell CSF induces granulocyte/macrophage colonies from bone marrow cells. This GM CSF has an apparent Mr of 22,000 as determined by gel-permeation chromatography. Treatment of L2-cell CSF with proteolytic enzymes abrogates biologic activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6363113

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  3 in total

1.  Granulocyte-macrophage colony-stimulating factor enhances the production of eosinophil chemotactic lymphokine by egg-associated granulomas of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; H Maruyama; Y Nawa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

2.  Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.

Authors:  M B Prystowsky; G Otten; M F Naujokas; J Vardiman; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

3.  Partial characterization of a fibroblast-stimulating factor produced by cloned murine T lymphocytes.

Authors:  P J Lammie; J G Monroe; A I Michael; G D Johnson; S M Phillips; M B Prystowsky
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.